Table 1 —

Clinical and metabolic characteristics in 35–70-year-old subjects with NGT, IFG/IGT, and diabetic (type 2) glucose tolerance

NGTIFG/IGTType 2 diabetes
n (F/M)1,988 (1133/855)798 (397/401)1,697 (804/893)
Age (years)50.5 ± 9.753.5 ± 10.058.6 ± 8.5
BMI (kg/m2)25.9 ± 3.727.3 ± 4.429.5 ± 4.9
WHR
 Men0.95 ± 0.060.96 ± 0.060.99 ± 0.06
 Women0.83 ± 0.070.84 ± 0.080.90 ± 0.07
Fasting plasma glucose (mmol/l)5.4 ± 0.56.1 ± 0.69.8 ± 3.3
HbA1c (%)5.3 ± 0.65.4 ± 0.67.5 ± 1.8
Fasting insulin (mU/l)*7.5 ± 4.510.4 ± 6.015.2 ± 11.2
HOMAIR*1.80 ± 1.132.83 ± 1.696.58 ± 5.87
Cholesterol (mmol/l)5.7 ± 1.15.8 ± 1.15.8 ± 1.1
HDL cholesterol (mmol/l)1.38 ± 0.361.27 ± 0.321.15 ± 0.3
Triglycericdes (mmol/l)1.29 ± 0.801.58 ± 0.862.08 ± 1.60
LDL cholesterol (mmol/l)3.77 ± 1.003.88 ± 0.993.78 ± 0.97
Lipid-lowering medication 0.5 1.4 1.7
Antihypertensive treatment15.521.946.3
Systolic blood pressure126.3 ± 16.2132.8 ± 16.6137.2 ± 17.0
Diastolic blood pressure77.9 ± 9.579.9 ± 9.580.5 ± 9.8
History of MI
 Men 3.2 7.113.4
 Women 1.0 1.3 5.8
Previous stroke 1.3 2.3 5.2
Current smoking
 Men  23  17  16
 Women  12  12  11
  • Data are means ± SD and %, unless otherwise indicated.

  • *

    * Insulin-treated patients excluded;

  • only untreated patients.